Abstract 4734: Reduced-Dose Direct Oral Anticoagulant versus Dual Antiplatelet Therapy After Left Atrial Appendage Closure in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis
Background: Reduced-dose direct oral anticoagulants (DOACs) are increasingly used after left atrial appendage closure (LAAC) in nonvalvular atrial fibrillation (NVAF), but their comparative efficacy and safety versus dual antiplatelet therapy (DAPT) remain uncertain, with no consensus on the optimal post-procedural...